Immunoglobulin (Ig) is an indispensable therapy used to treat many autoimmune disorders, immunosuppressive disorders, idiopathic diseases, infections, and a myriad of other conditions. Ig is a plasma-derived therapy that originates with a human donor. Production of Ig can take up to 12 months from the time plasma is donated to the time the product is released to market. Forecasting availability of Ig is complicated by the lengthy production cycle, volume of plasma donations, and product demand as well as regulatory or other manufacturing challenges. Listen as Luba Sobolevskyand James Sheets discuss the current Ig shortage and learn how nurses and care teams can help their patients.
¢ Luba Sobolevsky, PharmD, Executive Director, IgNS
¢ James L. Sheets, PharmD, CEO, CSI Pharmacy and IgNS Committee Member
¢ Dawn Berndt, DNP, RN, CRNI®, INS Infusion Nurse Educator